000			02045 a2200541 4500
005			20250515103356.0
264		0	_c20080331
008			200803s 0 0 eng d
022			_a1342-1751
024	7		_a10.1007/s10157-007-0001-x _2doi
040			_aNLM _beng _cNLM
100	1		_aGhorbanihaghjo, Amir
245	0	0	_aPrevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms. _h[electronic resource]
260			_bClinical and experimental nephrology _cFeb 2008
300			_a65-73 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_a8-Hydroxy-2'-Deoxyguanosine
650	0	4	_aAdult
650	0	4	_aAngiotensin II Type 1 Receptor Blockers _xtherapeutic use
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use
650	0	4	_aAtaxia Telangiectasia Mutated Proteins
650	0	4	_aBiomarkers _xblood
650	0	4	_aCell Cycle Proteins _xgenetics
650	0	4	_aDNA Damage _xdrug effects
650	0	4	_aDeoxyguanosine _xanalogs & derivatives
650	0	4	_aEnalapril _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKidney Transplantation _xmethods
650	0	4	_aLipid Peroxidation
650	0	4	_aLosartan _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMalondialdehyde _xblood
650	0	4	_aPeptidyl-Dipeptidase A _xgenetics
650	0	4	_aPolymorphism, Genetic
650	0	4	_aProtein Serine-Threonine Kinases _xgenetics
650	0	4	_aRenin-Angiotensin System _xgenetics
700	1		_aVeisi, Pegah
700	1		_aArgani, Hassan
700	1		_aAghaeishahsavari, Mohammad
700	1		_aNoroozianavval, Masood
700	1		_aRashtchizadeh, Nadereh
700	1		_aMesgari, Mehran
700	1		_aSafa, Javid
700	1		_aBabaei, Hosain
773	0		_tClinical and experimental nephrology _gvol. 12 _gno. 1 _gp. 65-73
856	4	0	_uhttps://doi.org/10.1007/s10157-007-0001-x _zAvailable from publisher's website
999			_c17685439 _d17685439